Department of Orthopaedics, Tianjin Orthopaedics Hospital, Tianjin, 300211, China. Electronic address: dongqiang1526@163.com. Department of Orthopaedics, Tianjin Orthopaedics Hospital, Tianjin, 300211, China. Department of Orthopaedics, Tianjin Orthopaedics Hospital, Tianjin, 300211, China. Department of Orthopaedics, Tianjin Orthopaedics Hospital, Tianjin, 300211, China.
International Journal of Surgery (London, England). 2018;52:156-163
OBJECTIVE This meta-analysis aimed to evaluate the safety and efficacy of aminocaproic acid in total knee arthroplasty (TKA) and total hip arthroplasty (THA). METHODS The electronic databases include PubMed, Medline, Embase, Web of Science and the Cochrane Library from inception to January 2018. Two reviewers abstracted total blood loss, hemoglobin drop, transfusion requirements, and postoperative complications. Data were using fixed-effects
or random-effects models with weighted mean differences and risk difference for continuous and dichotomous variables, respectively. STATA 14.0 was used to perform the meta-analysis. RESULTS Six studies encompassing 756 participants were retrieved for this meta-analysis. Our study indicated that intravenous aminocaproic acid was associated with a significantly reduction in total blood loss, hemoglobin drop and need for transfusion. Additionally, no increased risk of thromboembolic events were identified. CONCLUSION Based on the present meta-analysis, intravenous aminocaproic acid is effective and safe in total knee and hip arthroplasty without increasing the incidence of thromboembolic events. Further studies should focus on the comparison of aminocaproic acid and TXA in arthroplasties.
